N- {5-[4-(4-methyl-piperazino-methyl)-benz oylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyri midine-amine coated stents
Details for Australian Patent Application No. 2003214079 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 60/360,254 28.02.02 US
16 October 2003 Application Open to Public Inspection
Published as AU-B-2003214079
23 October 2003 Application Open to Public Inspection
Published as AU-B-2003214079
31 May 2007 Application Accepted
Published as AU-B-2003214079
27 September 2007 Standard Patent Sealed
24 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003214080-5-phenylthiazole derivatives and use as PI3 kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser